Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.52 |
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | CA2 | P00918 | 5/20 | 0.52 |
| ▸ | CA7 | P43166 | 5/20 | 0.52 |
| ▸ | CA9 | Q16790 | 5/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.52 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27138531 | 0.86 | KDM4E (0.46) | CA12CA1CA2CA7CA9 | |
| SCHEMBL25669658 | 0.85 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15009548 | 0.85 | TPMT (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2226012 | 0.83 | HSD17B10 (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5226978 | 0.83 | POLB (0.50) | CA1CA2POLBMAPTKDM4E | |
| SCHEMBL1271994 | 0.83 | KDM4E (0.61) | POLBMAPTRECQLKDM4ECYP3A4 | |
| SCHEMBL5262901 | 0.83 | KDM4E (0.39) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2318334 | 0.82 | CYP3A4 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2650424 | 0.82 | CA12 (0.58) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12112823 | 0.81 | CA12 (0.52) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2788366-B1 | PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS | DU PONT (US) | 2018-01-24 | — | — | EP | claimed |
| EP-2788366-A1 | PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS | E. I. Du Pont de Nemours and Company (US) | 2014-10-15 | — | — | EP | claimed |
| WO-2013085620-A1 | PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | WO | claimed |
| US-20130150612-A1 | PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2013-06-13 | — | — | US | claimed |
| EP-3635022-B1 | METHODS FOR MAKING FUNCTIONALIZED FLUORINATED MONOMERS, FLUORINATED MONOMERS, AND COMPOSITIONS FOR MAKING THE SAME | ETNA TEC LTD (US) | 2025-05-21 | — | — | EP | disclosed |
| US-20240352208-A1 | A Membrane and a Method of Making the Same | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2024-10-24 | — | — | US | disclosed |
| US-11820840-B2 | Compound, polymer, pattern forming material, and manufacturing method of semiconductor device | KIOXIA CORPORATION (JP) | 2023-11-21 | — | — | US | disclosed |
| US-20230220130-A1 | COMPOUND, POLYMER, PATTERN FORMING MATERIAL, AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE | KIOXIA CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| US-11639402-B2 | Polymer for pattern forming material | KIOXIA CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| US-20230117826-A1 | COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND METHODS OF USING SAME | MOLECULAR TARGETING TECHNOLOGIES, INC. | 2023-04-20 | — | — | US | disclosed |
| WO-2023033723-A2 | A MEMBRANE AND A METHOD OF MAKING THE SAME | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-03-09 | — | — | WO | disclosed |
| US-11492318-B2 | Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same | ETNA-TEC, LTD. (US) | 2022-11-08 | — | — | US | disclosed |
| EP-1095071-A1 | AROMATIC POLYMERS WITH PENDANT FLUORINATED IONIC GROUPS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2001-05-02 | — | — | EP | disclosed |
| WO-1999067304-A1 | AROMATIC POLYMERS WITH PENDANT FLUORINATED IONIC GROUPS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-12-29 | — | — | WO | disclosed |
| EP-0954531-A1 | aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES | Lajolla Pharmaceutical Company (US) | 1999-11-10 | — | — | EP | disclosed |
| EP-0954531-A4 | aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES | LAJOLLA PHARMACEUTICAL COMPANY (US) | 1999-08-31 | — | — | EP | disclosed |
| EP-0684963-B1 | WATER-DISSIPATABLE POLYESTERS AND AMIDES CONTAINING NEAR INFRARED FLUORESCENT COMPOUNDS COPOLYMERIZED THEREIN | EASTMAN CHEM CO (US) | 1998-07-29 | — | — | EP | disclosed |
| WO-1997046251-A9 | aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES | — | 1998-06-04 | — | — | WO | disclosed |
| WO-1997046251-A1 | aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES | LAJOLLA PHARMACEUTICAL COMPANY (US) | 1997-12-11 | — | — | WO | disclosed |
| US-5616659-A | Low flammability thermoset polymers | SOUTHWEST RESEARCH INSTITUTE (US) | 1997-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11820840-B2 | Compound, polymer, pattern forming material, and manufacturing method of semiconductor device | C9, H1-2, H1-3 | CA12 203/4885CA1 1124/4885CA2 3431/4885 |
| US-20130150612-A1 | PREPARATION OF (PHOSPHONYL) AROMATIC DIESTERS AND ACIDS | HRH3, PNN, H1-0 | CA12 2867/4885CA1 1786/4885CA2 1356/4885 |
| US-11492318-B2 | Methods for making functionalized fluorinated monomers, fluorinated monomers, and compositions for making the same | ALKBH3, FTO, ALK | CA12 1388/4885CA1 919/4885CA2 2671/4885 |
| US-20230117826-A1 | COMPOUNDS AND COMPOSITIONS FOR RETINAL INJURY DETECTION AND METHODS OF USING SAME | ALDH1A2, PDE6C, ALDH1A3 | CA12 2196/4885CA1 3362/4885CA2 1032/4885 |
| US-11639402-B2 | Polymer for pattern forming material | PUF60, METTL14, MECP2 | CA12 3127/4885CA1 4006/4885CA2 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.